Recurrent visceral leishmaniasis in an immunocompetent patient: a case report

INTRODUCTION: Current treatment options for visceral leishmaniasis (pentavalent antimony, amphotericin B, liposomal amphotericin B and mitelfosine) achieve long-term clinical cure in the majority of immunocompetent patients. Disease relapse is usually provoked by T-cell number or function impairment...

Descripción completa

Detalles Bibliográficos
Autores principales: Lagadinou, Maria, Dimitropoulou, Dimitra, Assimakopoulos, Stelios F, Davoulos, George, Marangos, Markos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601019/
https://www.ncbi.nlm.nih.gov/pubmed/23497385
http://dx.doi.org/10.1186/1752-1947-7-68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601019/
https://www.ncbi.nlm.nih.gov/pubmed/23497385
http://dx.doi.org/10.1186/1752-1947-7-68

Ejemplares similares